Listed

Phio Pharmaceuticals Corp.: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Nov 12, 2019 and accepted by EDGAR at Nov 12, 2019, 07:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-07-01 to 2019-09-30$0us-gaap:Revenues
Revenue9 months2019-01-01 to 2019-09-30$21.0kus-gaap:Revenues
Research and development3 months2019-07-01 to 2019-09-30$1.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-01-01 to 2019-09-30$3.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-07-01 to 2019-09-30−$2.1mus-gaap:OperatingIncomeLoss
Operating income9 months2019-01-01 to 2019-09-30−$6.3mus-gaap:OperatingIncomeLoss
Net income3 months2019-07-01 to 2019-09-30−$2.1mus-gaap:NetIncomeLoss
Net income9 months2019-01-01 to 2019-09-30−$6.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-30−$0.08us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2019-01-01 to 2019-09-30−$0.27us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2019-01-01 to 2019-09-30−$6.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-01-01 to 2019-09-30$77.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-09-30$8.7mus-gaap:Cash
Current assetsAt period end2019-09-30$9.3mus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$10.1mus-gaap:Assets
Current liabilitiesAt period end2019-09-30$2.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$2.5mus-gaap:Liabilities
Shareholders' equityAt period end2019-09-30$7.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001683168-19-003526. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.